Lexeo Therapeutics, Inc.’s LXEO share price has dipped by 9.71%, which has investors questioning if this is right time to buy ...

Researchers found that the two isoforms of connexin played an important role in accelerating ... may be a tool for assessing disease progression and iii) PAD inhibitor, BB-Cl-A, may be a promising ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

Researchers at Ben-Gurion University of the Negev have developed a machine-learning algorithm that could enhance our ...

Florey researchers have engineered a way to fool the immune system into accepting neural grafts as part of the body, rather ...

A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as melanoma, according to new research.

A medical breakthrough could result in the first treatment for rare but serious diseases in which genetic defects disrupt cellular energy production. Researchers have identified a molecule that helps ...

Here, we discover lysophospholipids as endogenous pannexin activators, using activity-guided fractionation of mouse tissue extracts combined with untargeted metabolomics and electrophysiology. We show ...

Clinical Infectious Disease s has launched a new series that will provide an in-depth look at real-life complex cases and the associated diagnostic and management decisions that ID clinicians deal ...

DNA methylation is a key factor in the regulation of organismal development and tissue homeostasis. DNA methylation marks indicate how to regulate ...

Neurodegenerative diseases are a heterogeneous group of disorders that are characterized by the progressive degeneration of the structure and function of the central nervous system or peripheral ...

Alzheimer's disease is a progressive neurodegenerative disease that impairs memory and cognitive judgment and is often accompanied by mood swings, disorientation and eventually delirium.